DB00746

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 1957
1994
gptkbp:ATCCode A10BA02
gptkbp:bioavailability 50-60%
gptkbp:CASNumber 657-24-9
gptkbp:color white
gptkbp:contraindication metabolic acidosis
hypersensitivity
renal impairment
gptkbp:drugClass biguanide
gptkbp:eliminationHalfLife 4-8.7 hours
gptkbp:excretion renal
gptkbp:form gptkb:tablet
extended-release tablet
gptkbp:hasDrugCategory antidiabetic agent
hypoglycemic agent
gptkbp:hasEssentialMedicineStatus gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:hasFirstApprovalCountry gptkb:France
gptkbp:hasInChIKey gptkb:XZWYZXLIPXDOLR-UHFFFAOYSA-N
gptkbp:hasMolecularFormula C4H11N5
gptkbp:hasSMILES CN(C)C(=N)N=C(N)N
gptkbp:hasUNII 9100L32L2N
https://www.w3.org/2000/01/rdf-schema#label DB00746
gptkbp:indication gptkb:type_2_diabetes_mellitus
gptkbp:legalStatus prescription only
off-patent
gptkbp:manufacturer gptkb:Bristol-Myers_Squibb
gptkbp:mechanismOfAction improves insulin sensitivity
decreases hepatic glucose production
decreases intestinal absorption of glucose
gptkbp:metabolism not metabolized
gptkbp:molecularWeight 129.164
gptkbp:name gptkb:Metformin
gptkbp:pregnancyCategory B (US)
gptkbp:proteinBinding negligible
gptkbp:PubChem_CID gptkb:CHEMBL1431
gptkb:D01841
gptkb:DB00746
4091
gptkbp:routeOfAdministration oral
gptkbp:sideEffect diarrhea
gastrointestinal upset
lactic acidosis
gptkbp:synonym gptkb:Glucophage
gptkb:Metformina
gptkb:Metformine
gptkb:Metforminum
gptkbp:target gptkb:AMP-activated_protein_kinase
gptkb:mitochondrial_respiratory_chain_complex_I
gptkbp:bfsParent gptkb:Deferoxamine
gptkbp:bfsLayer 6